Remternetug is an experimental anti-amyloid monoclonal antibody that targets pyroglutamate Aβ. It is developed by Eli Lilly and Company.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.